share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

週二盤前交易時段，12只醫療保健股走勢
Benzinga ·  03/26 21:05

Gainers

獲勝者

  • Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press release, Q4 earnings came out yesterday.
  • OpGen (NASDAQ:OPGN) shares moved upwards by 77.6% to $0.84. The market value of their outstanding shares is at $8.4 million.
  • ABVC BioPharma (NASDAQ:ABVC) stock increased by 45.71% to $1.53. The market value of their outstanding shares is at $16.1 million.
  • Mesoblast (NASDAQ:MESO) shares moved upwards by 32.27% to $2.91. The market value of their outstanding shares is at $295.3 million.
  • Praxis Precision Medicine (NASDAQ:PRAX) shares increased by 21.38% to $61.3. The market value of their outstanding shares is at $811.5 million.
  • Sutro Biopharma (NASDAQ:STRO) stock moved upwards by 18.96% to $3.89. The company's market cap stands at $237.1 million. The company's, Q4 earnings came out yesterday.
  • Stoke Therapeutics（納斯達克股票代碼：STOK）股價在週二的盤前交易中上漲了80.2％，至11.71美元。他們已發行股票的市值爲5.228億美元。根據新聞稿，第四季度業績於昨天公佈。
  • OPGen（納斯達克股票代碼：OPGN）股價上漲77.6％，至0.84美元。他們已發行股票的市值爲840萬美元。
  • ABVC BioPharma（納斯達克股票代碼：ABVC）股價上漲45.71％，至1.53美元。他們已發行股票的市值爲1,610萬美元。
  • Mesoblast（納斯達克股票代碼：MESO）股價上漲32.27％，至2.91美元。他們已發行股票的市值爲2.953億美元。
  • Praxis Precision Medicine（納斯達克股票代碼：PRAX）股價上漲21.38％，至61.3美元。他們已發行股票的市值爲8.115億美元。
  • Sutro Biopharma（納斯達克股票代碼：STRO）股價上漲18.96％，至3.89美元。該公司的市值爲2.371億美元。該公司昨天公佈了第四季度的收益。

Losers

失敗者

  • NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 55.0% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $1.6 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares fell 14.49% to $1.24. The company's market cap stands at $1.8 million. The company's, Q4 earnings came out yesterday.
  • bluebird bio (NASDAQ:BLUE) shares fell 12.51% to $1.19. The company's market cap stands at $229.3 million. As per the press release, Q4 earnings came out today.
  • BioLine Rx (NASDAQ:BLRX) stock declined by 11.54% to $1.15. The market value of their outstanding shares is at $83.3 million. The company's, Q4 earnings came out today.
  • iSpecimen (NASDAQ:ISPC) stock fell 8.48% to $0.23. The market value of their outstanding shares is at $2.0 million.
  • IMAC Hldgs (NASDAQ:BACK) stock decreased by 8.27% to $2.22. The company's market cap stands at $2.5 million.
  • 週二盤前交易中，NeuBase Therapeutics（納斯達克股票代碼：NBSE）股價下跌了55.0％，至0.45美元。該公司的市值爲160萬美元。
  • Tivic Health Systems（納斯達克股票代碼：TIVC）股價下跌14.49％，至1.24美元。該公司的市值爲180萬美元。該公司昨天公佈了第四季度的收益。
  • 藍鳥生物（納斯達克股票代碼：BLUE）股價下跌12.51％，至1.19美元。該公司的市值爲2.293億美元。根據新聞稿，第四季度業績今天公佈。
  • BioLine Rx（納斯達克股票代碼：BLRX）股價下跌11.54％，至1.15美元。他們已發行股票的市值爲8,330萬美元。該公司今天公佈了第四季度的收益。
  • iSpecimen（納斯達克股票代碼：ISPC）股價下跌8.48％，至0.23美元。他們已發行股票的市值爲200萬美元。
  • IMAC Hldgs（納斯達克股票代碼：BACK）股價下跌8.27％，至2.22美元。該公司的市值爲250萬美元。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論